International Healthcare Markets Will Benefit From Demographic Trends

Published
22 Mar 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$5.00
17.4% undervalued intrinsic discount
08 Aug
US$4.13
Loading
1Y
-11.8%
7D
-0.7%

Author's Valuation

US$5.0

17.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 4.94%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget has increased revenue growth from 1.6% to 2.2%.

Shared on02 Apr 25
Fair value Increased 0.19%

AnalystConsensusTarget has decreased revenue growth from 2.6% to 1.6%, decreased profit margin from 23.9% to 13.8%, increased future PE multiple from 17.0x to 30.5x and decreased shares outstanding growth rate from 0.0% to 0.0%.